Relistor (Subcutaneous)

From 178.3$

methylnaltrexone

Peripheral opioid receptor antagonists

Scoring is done by our AI based assistant on the data from the FDA and other sources

5.3

Effectiveness

Safety

Addiction

Ease of Use

Contraindications

abdominal painchillsdiarrheadiarrhea (severe)fearincreased sweatingnervousnesspersistent diarrheasevere abdominal painyawning

By Active Ingredients

7.5

Methylnaltrexone (Subcutaneous)

7.4

Relistor

By Action

7.8

Methylnaltrexone bromide (Oral)

7.5

Methylnaltrexone (Subcutaneous)

7.4

Alvimopan

7.4

Naldemedine

7.4

Relistor

7.4

Symproic